The webinar will discuss the Phase 1 Clinical Trial results on SMT C1100 for the treatment of Duchenne as well as outlining the next steps for this utrophin upregulator program. Jon Tinsley, Senior Director of R&D and Richard Pye, Head of Communications at Summit plc will give a presentation and answer questions that have been submitted. Questions must be submitted by Friday, December 7 at n…